The Hub for Disease-Specific Clinical Information
Advertisement
Advertisement

David G. Pfister, MD, on HPV-Positive Oropharyngeal Cancer: Deintensifying Chemoradiotherapy

Posted: Friday, March 22, 2019

David G. Pfister, MD, of Memorial Sloan Kettering Cancer Center, discusses when deintensified chemoradiotherapy is an option for patients with human papillomavirus–positive oropharyngeal cancer, and how it compares with standard-dose treatment in terms of outcomes.

Advertisement
Advertisement


By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.